Clinic
LA Casa De Buena Salud INC.
LA Casa De Buena Salud INC. was paid $19.37M by Medicaid between Jan 2018 and Dec 2024, across 123 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 37% of everything it billed.
33Billing provider infoLA CASA DE BUENA SALUD INC.
PORTALES, NM 88130
PORTALES, NM 88130
33aNPI1972603165assigned 09/25/2006
33bProvider typeFederally Qualified Health Center (FQHC)
28Total paid$19.37M
24GClaims235,299
24DCodes billed123
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Federally Qualified Health Center (FQHC) providers in New Mexico
Rank by total paid#3 of 80
Median peer was paid$1.11M
This provider vs. median17×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 45,448 | $3.68M | |
| 2019 | 45,536 | $3.94M | |
| 2020 | 35,943 | $3.63M | |
| 2021 | 33,541 | $3.64M | |
| 2022 | 26,335 | $2.47M | |
| 2023 | 17,518 | $936K | |
| 2024incomplete | 30,978 | $1.06M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 37% | 48,610 | 42,487 | $7.26M |
| D0999 | Unspecified diagnostic procedure, by report | 20% | 21,669 | 17,476 | $3.94M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14% | 18,694 | 16,601 | $2.63M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.0% | 5,966 | 5,950 | $975K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.3% | 5,000 | 4,481 | $825K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.8% | 4,463 | 4,456 | $736K |
| 99441 | 3.1% | 3,497 | 3,300 | $604K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.6% | 3,080 | 3,073 | $505K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.2% | 2,728 | 2,706 | $431K |
| 99442 | 1.5% | 1,645 | 1,587 | $284K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.4% | 5,774 | 5,712 | $264K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,162 | 1,099 | $165K |
111 more codes
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 980 | $146K |
| G0467 | Community health center visit, returning patient | <1% | 5,882 | $106K |
| 99381 | <1% | 444 | $70K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 378 | $60K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 291 | $45K |
| 99384 | <1% | 254 | $44K | |
| 1000F | <1% | 2,333 | $39K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 256 | $37K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 220 | $32K |
| 99383 | <1% | 195 | $31K | |
| 99443 | <1% | 163 | $28K | |
| 91301 | <1% | 894 | $18K | |
| 1159F | <1% | 3,996 | $14K | |
| 99460 | <1% | 80 | $13K | |
| 99382 | <1% | 67 | $10K | |
| 99385 | <1% | 65 | $10K | |
| 1126F | <1% | 1,271 | $7K | |
| 99462 | <1% | 39 | $5K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 8,747 | $5K |
| 90461 | <1% | 5,206 | $3K | |
| 90686 | <1% | 5,008 | $2K | |
| 1125F | <1% | 554 | $2K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 127 | $2K |
| 2001F | <1% | 4,253 | $2K | |
| 2000F | <1% | 3,087 | $1K | |
| D1120 | Dental cleaning, child | <1% | 2,454 | $1K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 206 | $1K |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 1,019 | $925.38 |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 1,320 | $803.32 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,763 | $691.87 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 416 | $639.04 |
| 81002 | <1% | 347 | $633.25 | |
| 90633 | <1% | 2,061 | $592.12 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 799 | $563.77 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,374 | $552.79 |
| 87807 | <1% | 411 | $536.38 | |
| 90696 | <1% | 925 | $474.04 | |
| 1220F | <1% | 876 | $447.73 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 125 | $435.50 |
| 90698 | <1% | 1,394 | $327.24 | |
| 90710 | <1% | 1,743 | $298.13 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 99 | $225.49 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 2,072 | $211.60 |
| 3044F | <1% | 298 | $194.39 | |
| 90670 | <1% | 3,279 | $173.84 | |
| 90681 | <1% | 1,051 | $173.84 | |
| D1110 | Prophylaxis - adult | <1% | 289 | $152.35 |
| 90733 | <1% | 930 | $150.10 | |
| 90648 | <1% | 1,924 | $148.03 | |
| 90700 | <1% | 836 | $148.03 | |
| 99000 | <1% | 507 | $148.03 | |
| 90651 | <1% | 938 | $148.03 | |
| 81003 | <1% | 2,311 | $76.40 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 536 | $41.95 |
| 90474 | <1% | 881 | $36.45 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 97 | $19.14 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 100 | $3.27 |
| 1160F | <1% | 3,845 | $0.16 | |
| 3008F | <1% | 3,311 | $0.15 | |
| 3078F | <1% | 2,463 | $0.10 | |
| 3074F | <1% | 2,874 | $0.10 | |
| 90657 | <1% | 79 | $0.04 | |
| D0220 | Intraoral - periapical first radiographic image | 0% | 2,862 | $0.00 |
| 90473 | 0% | 180 | $0.00 | |
| 90715 | 0% | 995 | $0.00 | |
| 91300 | 0% | 449 | $0.00 | |
| 3077F | 0% | 97 | $0.00 | |
| 90734 | 0% | 64 | $0.00 | |
| D0274 | Bitewings - four radiographic images | 0% | 906 | $0.00 |
| 81025 | 0% | 963 | $0.00 | |
| 90756 | 0% | 54 | $0.00 | |
| 90649 | 0% | 287 | $0.00 | |
| D0330 | Panoramic radiographic image | 0% | 16 | $0.00 |
| 87210 | 0% | 27 | $0.00 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 0% | 109 | $0.00 |
| 90658 | 0% | 34 | $0.00 | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | 0% | 16 | $0.00 |
| 3210F | 0% | 640 | $0.00 | |
| 0071A | 0% | 74 | $0.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 24 | $0.00 |
| 90707 | 0% | 75 | $0.00 | |
| 0002A | 0% | 27 | $0.00 | |
| D2140 | 0% | 16 | $0.00 | |
| 90672 | 0% | 20 | $0.00 | |
| D7140 | Extraction, erupted tooth or exposed root | 0% | 199 | $0.00 |
| 90723 | 0% | 1,048 | $0.00 | |
| D0272 | Bitewings - two radiographic images | 0% | 705 | $0.00 |
| D1206 | Topical application of fluoride varnish | 0% | 1,419 | $0.00 |
| D0230 | Intraoral - periapical each additional radiographic image | 0% | 2,439 | $0.00 |
| 3351F | 0% | 94 | $0.00 | |
| D0120 | Dental checkup, returning patient | 0% | 2,338 | $0.00 |
| 90744 | 0% | 470 | $0.00 | |
| 0001A | 0% | 60 | $0.00 | |
| D0140 | Limited oral evaluation - problem focused | 0% | 135 | $0.00 |
| 4000F | 0% | 243 | $0.00 | |
| 90716 | 0% | 74 | $0.00 | |
| 91307 | 0% | 319 | $0.00 | |
| D0601 | 0% | 75 | $0.00 | |
| D1351 | Sealant - per tooth | 0% | 366 | $0.00 |
| 3079F | 0% | 668 | $0.00 | |
| 82044 | 0% | 25 | $0.00 | |
| 3080F | 0% | 104 | $0.00 | |
| 91306 | 0% | 65 | $0.00 | |
| 3352F | 0% | 12 | $0.00 | |
| 90680 | 0% | 127 | $0.00 | |
| 3075F | 0% | 169 | $0.00 | |
| 0064A | 0% | 23 | $0.00 | |
| D0210 | Intraoral - complete series of radiographic images | 0% | 50 | $0.00 |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | 0% | 40 | $0.00 |
| 0072A | 0% | 35 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 31 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMONTANO, SEFERINO (CEO)
| Provider | Location | Paid |
|---|---|---|
| LA Casa De Buena Salud INC | Roswell, NM | $10.96M |
| LA Casa De Buena Salud INC | Clovis, NM | $2.53M |
| LA Casa De Buena Salud INC | Clovis, NM | $0.00 |
| LA Casa De Buena Salud INC | Roswell, NM | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.